Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation Factor V | cis | Discovery | rs6033 | 1:169,521,853 | A/G | 0.08 | 997 | -0.845 | 0.080 | 5.5×10-25 | -1.170 | 7.9×10-24 | 1.8×10-24 |
Coagulation Factor V | cis | Replication | rs6033 | 1:169,521,853 | A/G | 0.09 | 337 | -0.819 | 0.127 | 4.5×10-10 | -1.140 | 1.1×10-7 | 3.4×10-8 |
Target (abbrv.) | Coagulation Factor V |
Target (full name) | Coagulation Factor V |
Somalogic ID (Sequence ID) | SL000622 (4906-35_1) |
Entrez Gene Symbol | F5 |
UniProt ID | P12259 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Reactome |
|
Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs6033) and 8 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Trait | P | Study | Source |
---|---|---|---|
Serum ratio of (adrenate (22:4n6))/(oleate (18:1n9)) | 8.7×10-5 | 21886157 (PMID) | GRASP2 metabQTL |